Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Jeon, Won S ^a   Park, Ji W ^b   Lee, Namseok ^b   Park, Se E ^a   Rhee, Eun J ^a   Lee, Won Y ^a   Oh, Ki W ^a   Park, Sung W ^a   Park, Cheol Young ^a   Youn, Byung Soo ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b AdipoGen Inc   (South Korea)

Author keywords

Adiponectin; Microalbuminuria; Pulse wave velocity

Indexed keywords

ADIPONECTIN; ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROTEIN URINE LEVEL; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; CREATININE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PULSE WAVE ANALYSIS; REPUBLIC OF KOREA; RISK FACTORS; VASCULAR DISEASES; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84884625844     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-137     Document Type: Article

References (30)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749. 10.1074/jbc.270.45.26746, 7592907.
2. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes care 2003, 26:2015-2020. 10.2337/diacare.26.7.2015, 12832305.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm 1999, 257:79-83. 10.1006/bbrc.1999.0255, 10092513.
4. Park JY, Kim JW, Kim JM, Han Y, Park SK, Mok JY, Park MK, Lee HJ, Kim DK. Adiponectin concentrations in type 2 diabetic patients with or without metabolic syndrome. Korean diabetes journal 2008, 32:224-235.
5. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes care 2005, 28:1410-1414. 10.2337/diacare.28.6.1410, 15920060.
6. Amin R, Frystyk J, Ong K, Dalton RN, Flyvbjerg A, Dunger DB. The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes. Diabetologia 2008, 51:1707-1713. 10.1007/s00125-008-1081-1, 18622594.
7. Youn JC, Kim C, Park S, Lee SH, Kang SM, Choi D, Son NH, Shin DJ, Jang Y. Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol 2013, 163(3):316-319. 10.1016/j.ijcard.2011.06.061, 21724272.
8. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Katho T, Ohtsuka N. Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res 2011, 36:53-63. 10.3109/07435800.2010.534754, 21539444.
9. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. JASN 2002, 13:134-141.
10. Seon CS, Min KW, Lee SY, Nho KW, Park SH, Koo BK, Han KA. Cardiovascular risk assessment with vascular function, carotid atherosclerosis and the UKPDS risk engine in Korean patients with newly diagnosed type 2 diabetes. J Diabetes Metabol 2011, 35:619-627.
11. von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, et al. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes 2009, 58:2093-2099. 10.2337/db09-0204, 2731516, 19509019.
12. Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, Kakei M, Fujishima H, Ito S. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Comm 2004, 316:165-169. 10.1016/j.bbrc.2004.02.032, 15003525.
13. Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ, Lee WY, Oh KW, Kim SW, Park SW. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract 2009, 84:51-57. 10.1016/j.diabres.2009.01.002, 19187997.
14. Park SE, Kim WJ, Park SW, Park JW, Lee N, Park CY, Youn BS. High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur J Endocrinol 2013, 168:203-210. 10.1530/EJE-12-0782, 23144053.
15. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes care 2005, 28(Suppl 1):S37-S42. American Diabetes Association.
16. Yaturu S, Reddy RD, Rains J, Jain SK. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 2007, 37:1-5. 10.1016/j.cyto.2007.02.003, 17383891.
17. Shen YY, Hughes JT, Charlesworth JA, Kelly JJ, Peake PW. Adiponectin is present in the urine in its native conformation, and specifically reduces the secretion of MCP-1 by proximal tubular cells. Nephrology (Carlton) 2008, 13:405-410.
18. Hunt KJ, Williams K, Rivera D, O'Leary DH, Haffner SM, Stern MP, Gonzalez Villalpando C. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol 2003, 23:1845-1850. 10.1161/01.ATV.0000093471.58663.ED, 12958039.
19. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426. 10.1001/jama.286.4.421, 11466120.
20. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al. Adiponectin regulates albuminuria and podocyte function in mice. The Journal of clinical investigation 2008, 118:1645-1656. 2323186, 18431508.
21. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 2007, 27:1910-1917. 10.1161/ATVBAHA.107.147645, 17626903.
22. Shimotomai T, Kakei M, Narita T, Koshimura J, Hosoba M, Kato M, Komatsuda A, Ito S. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Renal failure 2005, 27:323-328.
23. Mahmud A, Feely J. Adiponectin and arterial stiffness. Am J Hypertens 2005, 18:1543-1548. 10.1016/j.amjhyper.2005.06.014, 16364823.
24. Park JS, Kang SA, Yoo JS, Ahn CW, Cha BS, Kim KR, Lee HC. Association between gamma-glutamyltransferase, adiponectin and arterial stiffness. J Atherosclerosis Thromb 2012, 19:90-97.
25. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, Tanaka H. Brachial-ankle pulse wave velocity: an index of central arterial stiffness?. J Hum Hypertens 2005, 19:401-406. 10.1038/sj.jhh.1001838, 15729378.
26. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004, 109:184-189. 10.1161/01.CIR.0000105767.94169.E3, 14662706.
27. Choi ES, Rhee EJ, Choi JH, Bae JC, Yoo SH, Kim WJ, Park SE, Park CY, Lee WY, Cho YK, et al. The association of brachial-ankle pulse wave velocity with 30-minute post-challenge plasma glucose levels in korean adults with no history of type 2 diabetes. Korean diabetes journal 2010, 34:287-293. 10.4093/kdj.2010.34.5.287, 2972488, 21076576.
28. Caselli C, Lionetti V, Cabiati M, Prescimone T, Aquaro GD, Ottaviano V, Bernini F, Mattii L, Del Ry S, Giannessi D. Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model. Cardiovasc Diabetol 2012, 11:143. 10.1186/1475-2840-11-143, 3537584, 23164042.
29. Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi A, Scarantino S, et al. Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol 2012, 11:151. 10.1186/1475-2840-11-151, 3558365, 23249664.
30. Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabol Clin Exp 2007, 56:1493-1499.